- Home
- CNTX vs LAW Comparison
CNTX vs LAW Comparison
Compare CNTX & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTX | LAW |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.9M | 271.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CNTX | LAW |
|---|---|---|
| Price | $2.25 | $4.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $6.60 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 747.3K | 175.4K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.39 | ★ 22.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $156,849,000.00 |
| Revenue This Year | N/A | $11.23 |
| Revenue Next Year | N/A | $10.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 8.29 |
| 52 Week Low | $0.49 | $2.45 |
| 52 Week High | $3.62 | $9.11 |
Technical Indicators
Market Signals| Indicator | CNTX | LAW |
|---|---|---|
| Relative Strength Index (RSI) | 41.64 | 50.95 |
| Support Level | $2.07 | $3.91 |
| Resistance Level | $2.58 | $4.77 |
| Average True Range (ATR) | 0.19 | 0.26 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 12.10 | 70.04 |
Price Performance
Historical ComparisonAbout CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.